Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01619813
Title Reolysin Combined With Docetaxel and Prednisone or Docetaxel and Prednisone Alone in Metastatic Castration Resistant Prostate Cancer
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors NCIC Clinical Trials Group
Indications
Therapies
Age Groups: adult
Covered Countries CAN

Facility Status City State Zip Country Details
Tom Baker Cancer Centre Calgary Alberta T2N 4N2 Canada Details
Cross Cancer Institute Edmonton Alberta T6G 1Z2 Canada Details
BCCA - Abbotsford Centre Abbotsford British Columbia V2S 0C2 Canada Details
BCCA - Cancer Centre for the Southern Interior Kelowna British Columbia V1Y 5L3 Canada Details
BCCA - Fraser Valley Cancer Centre Surrey British Columbia V3V 1Z2 Canada Details
BCCA - Vancouver Cancer Centre Vancouver British Columbia V5Z 4E6 Canada Details
Juravinski Cancer Centre at Hamilton Health Sciences Hamilton Ontario L8V 5C2 Canada Details
Cancer Centre of Southeastern Ontario at Kingston Kingston Ontario K7L 5P9 Canada Details
London Regional Cancer Program London Ontario N6A 4L6 Canada Details
Ottawa Hospital Research Institute Ottawa Ontario K1H 8L6 Canada Details
Allan Blair Cancer Centre Regina Saskatchewan S4T 7T1 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field